Skip to content

Clinical trials

Leukemia, Mast-Cell trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Leukemia, Mast-Cell Country / region: Germany Clear all

7 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20081
20151
20181
20201
20211
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed5
Recruiting1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Blueprint Medicines Corporation3
Cogent Biosciences, Inc.1
Deciphera Pharmaceuticals, LLC1
Fred Hutchinson Cancer Center1
Novartis Pharmaceuticals1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Leukemia, Mast-Cell7
Mastocytosis, Systemic6
Leukemia2
Leukemia, Myeloid, Acute2
Leukemia, Myelomonocytic, Chronic2
Myeloproliferative Disorders2
Blastic Plasmacytoid Dendritic Cell Neoplasm1
Burkitt Lymphoma1
Carcinoma, Non-Small-Cell Lung1
Congenital Abnormalities1

Trials

Showing 51 to 7 of 7. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.